HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production. [electronic resource]
Producer: 20031106Description: 6739-47 p. digitalISSN:- 0950-9232
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Blotting, Western
- Breast Neoplasms -- metabolism
- Cell Division
- Dose-Response Relationship, Drug
- Enzyme Inhibitors -- pharmacology
- Fenretinide -- metabolism
- Flow Cytometry
- Humans
- Immunohistochemistry
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase -- antagonists & inhibitors
- Receptor, ErbB-2 -- metabolism
- Trastuzumab
- Tretinoin -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.